PNAS paper shows that reduced quantities of miR-146a decreased silencing of cancer-promoting genes.



Researchers found a mutation through which papillary thyroid carcinoma (PTC), the most common form of thyroid cancer, is passed down through families.


First-degree relatives of PTC patients have a three- to eightfold greater risk of developing the disease than others. Even with this strong genetic component, previous research has not been able to find a mutation that predispose people to the affliction within any of the know tumor-associated genes.


In the current study, investigators examined how these genes are being regulated.  They identified a variant in the pre-miR-146a sequence that reduces the quantity of miR-146a, which is needed to regulate other genes. The investigators also showed that when miR-146a levels fall, two specific genes involved in tumor promotion are not inhibited as efficiently, leading to a greater risk of cancer.


The scientists involved in the research were from the Ohio State University, Helsinki University Central Hospital, and Maria Sklodowska-Curie Memorial Cancer Center and Institute of Oncology. The study was published May 12 in Proceedings of the National Academy of Science.








This site uses Akismet to reduce spam. Learn how your comment data is processed.